Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Scientific Reports|June 10, 2021
BING, a novel antimicrobial peptide isolated from Japanese medaka plasma, targets bacterial envelope stress response by suppressing cpxR expressionMiao Dong, Shu Hin Kwok, Joseph L Humble, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 29, 2025
Proteasomes suppress anticancer drug-induced cytotoxicity by inhibiting mitochondrial protein import and promoting ROS-BNIP3-mediated mitophagyLing Li, Yangyang Feng, Jingbo Zhou, et al.Nature Structural & Molecular Biology|May 15, 2025
Reciprocal stabilization of CtBP and TRIM28 represses autophagy to promote metastasisLixin Tai, Dongliang Zhu, Ping Tang, et al.Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|December 4, 2025
Lars2-signaling mediates platinum resistance by accumulating cancer stem cell population and suppressing anti-tumor immunityYuqing Wang, Min Deng, Haipeng Lei, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 13, 2025
CDK4/6 Inhibition Induces CD8+ T Cell Antitumor Immunity via MIF-Induced Functional Orchestration of Tumor-Associated MacrophagesLin He, Yuzhong Peng, Lat-Lun Leong, et al.Cell Death & Disease|March 29, 2025
Oncogenic activation of SMYD3-SHCBP1 promotes breast cancer development and is coupled with resistance to immune therapyLihua Mo, Min Deng, Ragini Adhav, et al.Bioactive Materials|March 10, 2025
Establishing a cryopreserved biobank of living tumor tissues for drug sensitivity testingPing Chen, Jing-Bo Zhou, Xiang-Peng Chu, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 13, 2021
Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to ImmunotherapyJosh Haipeng Lei, Mi-Hye Lee, Kai Miao, et al.Nature Communications|March 19, 2022
S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapyJianjie Li, Xiaodong Shu, Jun Xu, et al.Journal for Immunotherapy of Cancer|January 29, 2026
DUSP22 dephosphorylates LGALS1 to enhance T cell-driven antitumor immunityLijian Wang, Yutong Guo, Yujie Dai, et al.Pageof 5